Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: Migratory Polyarthritis as the Presenting Symptom of GPA

Adil Vural, MD, & Kinanah Yaseen, MD  |  Issue: May 2023  |  May 9, 2023

Click to enlarge.

Review of systems: He reported migratory polyarthritis, recent ocular pain and redness, and chronic low back pain and stiffness. The patient denied any skin rash, such as psoriasis; constitutional symptoms, including fever, chills, weight loss and night sweats; dactylitis; gastrointestinal or genitourinary symptoms; nasal discharge, crusting or bleeding; nasal or auricular chondritis; sinus or respiratory symptoms, such as cough, hemoptysis or shortness of breath; sore throat; numbness or tingling sensation in his extremities; recent infection, including sexually transmitted disease; or tick bite preceding his symptoms.

Physical examination & laboratory evaluation: Upon evaluation, the patient was afebrile (98ºF), had a blood pressure of 123/83 mmHg, a heart rate of 90 beats per minute and a normal respiratory rate.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

He was well appearing and not in acute distress. He had clear sclera, without focal sinus tenderness, nasal crusting or deformity. His skin examination was normal, without evidence of psoriasis, nodules or purpuric rash. The lung auscultation was clear. The patient didn’t have any pitting edema in his lower extremities.

The musculoskeletal examination revealed no active synovitis in his joints, except for focal tenderness in both ankles without apparent effusion, and a Schober’s test was limited (i.e., 10–13 cm), without focal tenderness over his sacroiliac joints or the rest of his spine.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Differential Diagnoses

The differential diagnosis for migratory polyarthritis includes palindromic rheumatism, infectious processes, such as Lyme disease and viral infections, spondyloarthropathy, sarcoidosis, connective tissue disorders and vasculitides and paraneoplastic polyarthritis.3

Palindromic rheumatism: A rare inflammatory arthritis, palindromic rheumatism is characterized by recurrent attacks, manifesting as joint pain and swelling without chronic joint damage. Episodes are self-limited, resolving within a few hours to days. Patients with anti-cyclic citrullinated peptide (CCP) antibodies are at increased risk to progress into rheumatoid arthritis (RA) in up to 50% of cases.

Our patient presented with migratory polyarthritis without constitutional symptoms and had a positive rheumatoid factor (RF) test, which would put palindromic rheumatism high on the list of possible diagnoses. However, whereas episcleritis and scleritis are both reported in RA, a history of iritis is not usually a common symptom.4,5

Infectious causes: Viral and bacterial infections, such as parvovirus B19, may cause migratory polyarthritis by a reactive process. It may present as asymmetric oligoarthritis in children; in adults it tends to manifest as symmetrical polyarthritis.6 Hepatitis B can present prodromal symptoms, symmetrical polyarthritis and a positive RF test in up to 80% of cases.7

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:AAV FocusRheumANCA-Associated Vasculitiscase reportGranulomatosisgranulomatosis with polyangiitismigratory polyarthritis

Related Articles

    ANCA-Associated Vasculitis Trial Results May Change Standard of Care

    May 15, 2020

    SNOWMASS VILLAGE, COLO.—The study of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) is ongoing, and research results should help improve treatment for this patient pop­ulation. Key trials and therapeutic options were discussed at the 2020 ACR Winter Symposium during the session, Update on the Treatment of ANCA-Associated Vasculitis, by Peter A. Merkel, MD, MPH, chief of…

    Mortality from Anti-neutrophil Cytoplasmic Autoantibody-Associated Vasculitis Falling Slightly

    October 9, 2019

    NEW YORK (Reuters Health)—Mortality rates in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis (AAV) decreased from 1999 to 2017, according to records from the Centers for Disease Control and Prevention (CDC). “The mortality attributed to several rare diseases [e.g., hypersensitivity pneumonitis] has increased in recent years,” Alexander W. Steinberg, MD, from Saint Joseph Hospital, Denver, tells…

    Trimethoprim-Sulfamethoxazole Prophylaxis Reduced Rituximab Infection Risk

    October 18, 2018

    Severe infections occurred in 25% of patients with anti-neutrophil cytoplasm antibody (ANCA) associated vasculitis (AAV) who were treated with rituximab, according to results of an observational study conducted in the United Kingdom (U.K.) and Austria. Trimethoprim-sulfamethoxazole (TMP/SMX) prophylaxis, however, reduced the risk of severe infections, the investigators reported in Annals of the Rheumatic Diseases.1 Andreas…

    ANCA Mortality: Are Patients Doing Better?

    December 13, 2019

    Patients with anti-neutrophil cytoplasmic antibody–associated vasculitides (AAV) have an increased risk of mortality. But treatments have evolved in recent years. Recent research found that between 1999 and 2017 the AAV mortality rate declined by nearly 2% per year in patients 65–74 years old…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences